B
Baoying Huang
Researcher at Chinese Center for Disease Control and Prevention
Publications - 5
Citations - 1113
Baoying Huang is an academic researcher from Chinese Center for Disease Control and Prevention. The author has contributed to research in topics: Virus & Lung. The author has an hindex of 3, co-authored 5 publications receiving 811 citations.
Papers
More filters
Journal ArticleDOI
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
Linlin Bao,Wei Deng,Baoying Huang,Hong Gao,Jiangning Liu,Lili Ren,Qiang Wei,Pin Yu,Yanfeng Xu,Feifei Qi,Yajin Qu,Fengdi Li,Qi Lv,Wenling Wang,Jing Xue,Shuran Gong,Mingya Liu,Guanpeng Wang,Shunyi Wang,Zhiqi Song,Linna Zhao,Peipei Liu,Li Zhao,Fei Ye,Huijuan Wang,Weimin Zhou,Na Zhu,Wei Zhen,Haisheng Yu,Xiaojuan Zhang,Li Guo,Lan Chen,Conghui Wang,Ying Wang,Xinming Wang,Yan Xiao,Qiangming Sun,Hongqi Liu,Fanli Zhu,Chunxia Ma,Lingmei Yan,Mengli Yang,Jun Han,Wenbo Xu,Wenjie Tan,Xiaozhong Peng,Qi Jin,Guizhen Wu,Chuan Qin +48 more
TL;DR: This mouse model of SARS-CoV-2 infection will be valuable for evaluating antiviral therapeutic agents and vaccines, as well as understanding the pathogenesis of COVID-19.
Posted ContentDOI
The Pathogenicity of 2019 Novel Coronavirus in hACE2 Transgenic Mice
Linlin Bao,Wei Deng,Baoying Huang,Hong Gao,Lili Ren,Qiang Wei,Pin Yu,Yanfeng Xu,Jiangning Liu,Feifei Qi,Yajin Qu,Wenling Wang,Fengdi Li,Qi Lv,Jing Xue,Shuran Gong,Mingya Liu,Guanpeng Wang,Shunyi Wang,Linna Zhao,Peipei Liu,Li Zhao,Fei Ye,Huijuan Wang,Weimin Zhou,Na Zhu,Wei Zhen,Haisheng Yu,Xiaojuan Zhang,Zhiqi Song,Li Guo,Lan Chen,Conghui Wang,Ying Wang,Xinming Wang,Yan Xiao,Qiangming Sun,Hongqi Liu,Fanli Zhu,Chunxia Ma,Lingmei Yan,Mengli Yang,Jun Han,Wenbo Xu,Wenjie Tan,Xiaozhong Peng,Qi Jin,Guizhen Wu,Chuan Qin +48 more
TL;DR: Wang et al. as discussed by the authors found the pathogenicity of 2019-nCoV in hACE2 mice, and the Koch's postulates were fulfilled as well, and they may facilitate the development of therapeutics and vaccines against 2019 nCoV.
Posted ContentDOI
The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice
Linlin Bao,Wei Deng,Baoying Huang,Hong Gao,Jiangning Liu,Lili Ren,Qiang Wei,Pin Yu,Yanfeng Xu,Feifei Qi,Yajin Qu,Fengdi Li,Qi Lv,Wenling Wang,Jing Xue,Shuran Gong,Mingya Liu,Guanpeng Wang,Shunyi Wang,Zhiqi Song,Linna Zhao,Peipei Liu,Li Zhao,Fei Ye,Huijuan Wang,Weimin Zhou,Na Zhu,Wei Zhen,Haisheng Yu,Xiaojuan Zhang,Li Guo,Lan Chen,Conghui Wang,Ying Wang,Xinming Wang,Yan Xiao,Qiangming Sun,Hongqi Liu,Fanli Zhu,Chunxia Ma,Lingmei Yan,Mengli Yang,Jun Han,Wenbo Xu,Wenjie Tan,Xiaozhong Peng,Qi Jin,Guizhen Wu,Chuan Qin +48 more
TL;DR: The pathogenicity of Sars-CoV-2 in hACE2 mice was clarified and the Koch’s postulates were fulfilled, and the mouse model may facilitate the development of therapeutics and vaccines against SARS-Cov-2.
Patent
Application of phenazopyridine to preparation of broad-spectrum anti-coronavirus medicine
TL;DR: Wang et al. as discussed by the authors revealed application of phenazopyridine to preparation of broad-spectrum anti-coronavirus medicine and showed the dosage effect relevancy.
Patent
Application of mycophenolic acid and its derivative mycophenolate mofetil in preparation of broad-spectrum anti-coronavirus drugs
TL;DR: In this paper, a broad-spectrum application of mycophenolic acid and its derivatives in the preparation of broad spectrum anti-coronavirus drugs has been revealed.